参考文献
1.NCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines): Rectal Cancer Version 1.2019— March 15, 2019.
2.American Joint Committee on Cancer(AJCC)Cancer Staging System(8th ed., 2017).
3.Higurashi T, Hosono K, Takahashi H, et al.Metformin for chemoprevention of metachronous colorectal adenoma or polyps in postpolypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.Lancet Oncol 2016, 17: 475-483.
4.Sloothaak DA, Sahami S, van der Zaag-Loonen HJ, et al.The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis.Eur J Surg Oncol 2014, 40: 263-269.
5.Yagi R, Shimada Y, Kameyama H, et al.Clinical significance of extramural tumor deposits in the lateral pelvic lymph node area in low rectal cancer: a retrospective study at two institutions.Ann Surg Oncol 2016, 23: 552-558.
6.Al-Sukhni E, Attwood K, Gabriel EM, et al.Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study.Int J Surg 2016, 37: 42-49.
7.Balyasnikova S, Brown G.Optimal imaging strategies for rectal cancer staging and ongoing management.Curr Treat Options Oncol 2016, 17: 32.
8.Faletti R, Gatti M, Arezzo A, et al.Preoperative staging of rectal cancer using magnetic resonance imaging: comparison with pathological staging.Minerva Chir 2018, 73: 13-19.
9.Ryan JE, Warrier SK, Lynch AC, et al.Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.Colorectal Dis 2015, 17: 849-861.
10.Chen Y, Guo R, Xie J, et al.Laparoscopy combined with transanal endoscopic microsurgery for rectal cancer: A prospective, single-blinded, randomized clinical trial.Surg Laparosc Endosc Percutan Tech 2015, 25: 399-402.
11.Russell MM, Ganz PA, Lopa S, et al.Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patientreported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04.Ann Surg 2015, 261: 144-148.(https://www.daowen.com)
12.Miskovic D, Foster J, Agha A, et al.Standardization of laparoscopic total mesorectal excision for rectal cancer: a structured international expert consensus.Ann Surg 2015, 261: 716-722.
13. Feng YR, Zhu Y, Liu LY, et al.Interim analysis of postoperative chemoradiotherapy with capecitabine and oxaliplatin versus capecitabine alone for pathological stage II and III rectal cancer: a randomized multicenter phase III trial.Oncotarget 2016, 7: 25576-25584.
14.Petrelli F, Sgroi G, Sarti E, et al.Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a metaanalysis of published studies.Ann Surg 2016, 263: 458-464.
15.Dossa F, Chesney TR, Acuna SA, et al.A watch-andwait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol 2017, 2: 501-513.
16.Loree JM, Kennecke HF, Lee-Ying RM, et al.Impact of postoperative adjuvant chemotherapy following longcourse chemoradiotherapy in stage II rectal cancer.Am J Clin Oncol 2016.
17.Hu X, Li YQ, Li QG, et al.Adjuvant chemotherapy seemed not to have survival benefit in rectal cancer patients with ypTis-2N0 after preoperative radiotherapy and surgery from a population-based propensity score analysis.Oncologist 2018.
18.Borstlap WA, Coeymans TJ, Tanis PJ, et al.Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant(chemo)radiotherapy or completion surgery.Br J Surg 2016, 103: 1105-1116.
19.Gonzalez M, Gervaz P.Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis.Future Oncol 2015, 11: 31-33.
20.Zacharias AJ, Jayakrishnan TT, Rajeev R, et al.Comparative effectiveness of hepatic artery based therapies for unresectable colorectal liver metastases: a meta-analysis.PLoS One 2015, 10: e0139940.
21. Nagayama S, Hasegawa S, Hida K, et al.Multiinstitutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.Int J Clin Oncol 2017, 22: 316-323.